Acasti Pharma Inc. reported earnings results for the third quarter and nine months ended November 30, 2013. For the quarter, the company reported revenue of $28,000 against of $424,000 for the same period a year ago. Adjusted LBITDA was $1,574,000 compared to $1,048,000 for the same period a year ago. Net loss was $3,856,000 or $0.05 per share was recorded for the current quarter against a net loss of $1,611,000 or $0.02 per share in the same quarter last year.

For the nine months, the company reported revenue of $301,000 against of $675,000 for the corresponding period ended November 30, 2012. Adjusted LBITDA was $4,607,000 against of $3,024,000 in the corresponding prior-year period. Net loss was $9,059,000 or $0.12 per share was recorded for the nine-month period ended November 30, 2013, against a net loss of $4,940,000 or $0.07 per share in the corresponding prior-year period.